Skip to main content
Clinical Trials/ISRCTN13141364
ISRCTN13141364Active, not recruiting未知

Strengthening oropharyngeal muscles as a novel approach to treat obstructive sleep apnea : a randomized feasibility study

Sunnybrook Health Science Centre0 sites45 target enrollmentStarted: January 9, 2023Last updated:

Trial Snapshot

Phase
未知
Status
Active, not recruiting
Sponsor
Enrollment
45

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. With OSA (defined as an apnea-hypopnea index =10/h) in whom >50% of the respiratory events are obstructive in nature
  • 2. Unwilling to use CPAP or have been unable to tolerate CPAP after at least a 2-week trial
  • 3. Not using an equipment-based treatment modality (e.g. PAP therapy, a dental appliance, or hypoglossal nerve stimulation) or surgery to manage their OSA

Exclusion Criteria

  • 1. Planned airway surgery, use of CPAP, a dental appliance, or other equipment-based treatment modality to manage OSA during the course of the study
  • 2. Central respiratory events account for =50% of the overall apnea-hypopnea index
  • 3. Reduced cognition (Montreal Cognitive Assessment [MoCA] <18)
  • 4. Any significant neurological condition that could impact oropharyngeal activity
  • 5. Use of medications that may impact the tone of the upper airway (e.g. hypnotics, opiates) =3 nights per week during the 4 weeks prior to randomization
  • 6. Use of a medical device that would interfere with the use of the home sleep apnea test
  • 7. Plans to move to another city during the study that would impact compliance. As it would be unethical to withhold CPAP therapy (current first-line therapy for moderate to severe OSA), we will only be recruiting patients who are unwilling to use CPAP therapy or those who are unable to tolerate CPAP after at least a 2-week trial

Investigators

Sponsor
Sunnybrook Health Science Centre

Similar Trials